Insider Trading April 1, 2026

Cheniere Energy Executive Disposes $8.7M in Shares; Company Posts Strong Q4 2025 Results

EVP and CFO Zach Davis sold 29,000 shares at $300 apiece as Cheniere reports robust adjusted EBITDA and net income for the quarter

By Sofia Navarro LNG
Cheniere Energy Executive Disposes $8.7M in Shares; Company Posts Strong Q4 2025 Results
LNG

Cheniere Energy EVP and CFO Zach Davis sold 29,000 shares of common stock on March 30, 2026, for $300 per share, a transaction valued at $8.7 million. After the sale Davis holds 87,146 shares. Independent valuation commentary cites potential overvaluation versus Fair Value despite a P/E of 11.38. Separately, Cheniere reported strong fourth-quarter 2025 results, including consolidated adjusted EBITDA of $2.0 billion and net income of $2.3 billion.

Key Points

  • Cheniere EVP and CFO Zach Davis sold 29,000 shares on March 30, 2026, at $300 per share, totaling $8.7 million.
  • After the sale Davis directly holds 87,146 shares; the sale was reported as for diversification and tax planning.
  • Cheniere reported strong Q4 2025 financial results: consolidated adjusted EBITDA of $2.0 billion and net income of $2.3 billion; InvestingPro cites potential overvaluation relative to Fair Value while noting a P/E of 11.38.

Cheniere Energy, Inc. (NYSE: LNG) disclosed an insider stock sale by Executive Vice President and Chief Financial Officer Zach Davis in a Form 4 filing with the Securities and Exchange Commission. According to the filing, Davis sold 29,000 shares of Cheniere common stock on March 30, 2026, at a price of $300 per share, producing total proceeds of $8.7 million.

Following the disposition, Davis’ direct holdings in Cheniere stand at 87,146 shares. The filing states the transaction was undertaken for diversification and tax planning purposes.

Independent valuation commentary included in the broader disclosure notes that, per InvestingPro analysis, Cheniere’s shares appear overvalued when compared to the service’s Fair Value assessment. The same analysis also points out an attractive price-to-earnings ratio of 11.38. The InvestingPro Pro Research Report is referenced as a source of more detailed valuation work for LNG and more than 1,400 U.S. equities.


In separate company disclosures, Cheniere reported solid operating and financial outcomes for the fourth quarter of 2025. Management announced consolidated adjusted EBITDA of $2.0 billion for the quarter, alongside net income of $2.3 billion. Company commentary attributed these results to an emphasis on operational efficiency and commercial execution.

Analysts cited in the company update noted the firm’s robust quarterly performance; the available information does not indicate any resulting analyst upgrades or downgrades. The firm’s reported results were presented as evidence of continued ability to capture market opportunities and to strengthen its financial and operating position.

This report presents the transaction details and the company’s reported quarterly results as disclosed. The insider sale, valuation commentary from InvestingPro, and Cheniere’s fourth-quarter financial metrics are reported facts drawn from the filings and company statements.

Risks

  • Valuation uncertainty - InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value, a consideration for equity investors and market participants.
  • Analyst reaction unknown - while analysts noted robust performance, the disclosure does not report any upgrades or downgrades, leaving the external market response unclear.
  • Insider selling - the CFO's sale, even if executed for diversification and tax planning, reduces insider-held shares and may be viewed by some investors as a change in executive ownership exposure.

More from Insider Trading

Capricor EVP Krasney Completes $752,935 Share Sale, Exercises 25,000 Options Apr 1, 2026 Capricor CFO Disposes $753K in Shares, Exercises Options as Clinical and Financial Milestones Draw Focus Apr 1, 2026 RH Director Disposes of 11,000 Shares in $1.5M Transaction; Options Exercised as Analysts Adjust Targets Apr 1, 2026 Capricor Therapeutics Director Disposes of $3.5M in Shares After Exercising Options Apr 1, 2026 Director Ault Acquires Additional Universal Safety Products Shares; Company Converts Note to Equity Apr 1, 2026